Medicity

Aethlon Hemopurifier. Photo: Aethlon Medical, Inc.

Hepatitis C Undetectable after 7 Days in New Genotype-1 Patients Study

By on July 31, 2012

Two recent hepatitis c (HCV) infected patients to receive Hemopurifier® therapy in combination with peginterferon+ribavirin (PR) drug therapy achieved undetectable viral load at day-7, representing a significant clinical milestone in HCV care. T

Posted in , | Tagged , , , , , , , | Leave a response